$1.36 +0.03 (2.13%)

ZYNEX INC (ZYXI)

Zynex Inc. (ZYXI) is a healthcare company that develops and markets medical devices focused on pain management, physical therapy, and neuromuscular stimulation. Founded in 2003 and based in Colorado, it primarily offers products for hospitals, clinics, and home use, aiming to provide non-invasive solutions for pain relief and muscle rehabilitation.

Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
January 21, 2022$0.102022-01-052022-01-06
January 18, 2019$0.072018-12-312019-01-02

Dividends Summary

Company News

ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • September 27, 2025

Law firm investigating potential claims against Zynex for allegedly artificially inflating stock price through misleading statements about financial performance and insurance reimbursement practices, leading to significant stock price decline after Tricare payment suspension.

All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy
Zacks Investment Research • Zacks Equity Research • June 26, 2024

Zynex (ZYXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wall Street Breakfast: The Week Ahead
Seeking Alpha • Wall Street Breakfast • May 5, 2024

Discover the upcoming events and earnings reports in the financial market, including notable companies like Disney, Tyson Foods, and Uber.

AMD, Yum China, Paycom Software And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga • Lisa Levin • November 1, 2023

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Paycom Software, Inc. (NYSE: PAYC) shares dipped 37.1% to $154.15 in pre-market trading after the company reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below es...

Why Shares of Zynex Are Up Wednesday
The Motley Fool [email protected] (Jim Halley) • June 14, 2023

After buying back $30 million in stock over the past 12 months, the company is now planning a $10 million stock buyback.